市場調査レポート

商品コード

1608891

化学療法市場：薬剤別、がんの種類別、投与経路別、流通チャネル別、地域別

Chemotherapy Market, By Drugs, By Cancer Type, By Route of Administration, By Distribution Channel, By Geography

出版日: 2024年11月25日
発行: Coherent Market Insights
ページ情報: 英文 145 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 661,455円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,028,930円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,469,900円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

化学療法市場は2024年に108億7,000万米ドルと推定され、2031年には183億5,000万米ドルに達すると予測され、2024年から2031年までのCAGRは7.8%です。

分析範囲		分析詳細
基準年	2023年	市場規模 (2024年)	108億7,000万米ドル
実績データ	2019～2023年	予測期間	2024～2031年
予測期間のCAGR (2024～2031年)	7.80%	予測金額 (2031年)	183億5,000万米ドル

図：化学療法の市場シェア (%)、2024年、地域別

化学療法は、標準化された化学療法レジメンの一部として1種類以上の抗がん剤を使用するがん治療の一種です。化学療法薬は、正常細胞よりも急速に増殖、分裂、拡散するがん細胞の成長を遅らせたり、止めたりすることで効果を発揮します。化学療法は、乳がん、肺がん、大腸がん、リンパ腫、白血病、膀胱がん、精巣がん、卵巣がんなど、多くの種類のがんの治療に用いられます。化学療法は静脈注射で行われることが多いが、経口投与や局所投与も可能です。化学療法は通常、周期的に行われ、各治療期間の後には、体が健康な新しい細胞を作るための回復期間が続きます。副作用は、使用する薬剤、投与量、患者によって異なるが、疲労、食欲不振、吐き気、嘔吐、脱毛、口内炎、免疫力の低下などがあります。

市場力学：

様々な種類のがんの有病率の上昇と、がんを発症しやすくなっている高齢者人口の増加は、今後数年間の化学療法市場の成長を促進すると予想される重要な要因です。さらに、標的薬物療法や個別化医療に対する需要の高まり、ドラッグデリバリーシステムの技術的進歩、臨床開発中の新規化学療法剤の強力なパイプラインは、市場の拡大をさらに促進すると思われます。しかし、化学療法剤に伴う毒性や副作用、薬剤耐性のリスク、抗がん剤の高コスト、新興諸国における医療インフラや意識の欠如などが、予測期間を通じて市場をある程度抑制する可能性が高いです。毒性を低減し、有効性を向上させる革新的な薬剤送達システムの開発と抗がん剤の標的送達は、この市場の参入企業にとって有望な機会を保持しています。

当研究の主な特徴

当レポートは、世界の化学療法市場を詳細に分析し、2023年を基準年とした予測期間 (2024-2031年) の市場規模および複合年間成長率 (CAGR、%) を提供します。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
世界の化学療法市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて掲載しています。
当レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、種類の刷新、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
世界の化学療法市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界の化学療法市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	10.87 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.80%	2031 Value Projection:	18.35 Bn

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy drugs work by slowing or stopping the growth of cancer cells which grow, divide, and spread more rapidly than normal cells. Chemotherapy is used to treat many types of cancers including breast cancer, lung cancer, colorectal cancer, lymphoma, leukemia, bladder cancer, testicular cancer, ovarian cancer, and others. It is often given intravenously but can also be given by mouth or topically. Chemotherapy is usually given in cycles with each period of treatment followed by a recovery period to allow the body to build healthy new cells. Side effects depend on the specific drugs used, dosage, and the patient but can include fatigue, loss of appetite, nausea, vomiting, hair loss, mouth sores, and lowered immunity.

Market Dynamics:

The rising prevalence of various types of cancers and the growing geriatric population, which is increasingly susceptible to developing cancer, are significant factors expected to drive the growth of the chemotherapy market in the coming years. Additionally, the increasing demand for targeted drug therapies and personalized medicine, along with technological advancements in drug delivery systems and a strong pipeline of novel chemotherapy agents in clinical development, will further enhance market expansion. However, the toxicity and side effects associated with chemotherapy drugs, risk of drug resistance, high costs of cancer drugs, and lack of healthcare infrastructure and awareness in developing countries are likely to restrain the market to a certain extent over the forecast period. Development of innovative drug delivery systems to reduce toxicity and improve efficacy and targeted delivery of anti-cancer drugs hold promising opportunities for players in this market.

Key Features of the Study:

This report provides in-depth analysis of the global chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., AbbVie Inc., Merck & Co., Inc., Eureka Therapeutics, Inc., Verismo Therapeutics, Inc., Bayer AG, and Autolus Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chemotherapy market

Market Segmentation

By Drugs Insights (Revenue, USD Bn, 2019 - 2031)
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
By Cancer Type Insights (Revenue, USD Bn, 2019 - 2031)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Others
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- AbbVie Inc.
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- Verismo Therapeutics, Inc.
- Bayer AG
- Autolus Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Chemotherapy Market, By Drugs
- Chemotherapy Market, By Cancer Type
- Chemotherapy Market, By Route of Administration
- Chemotherapy Market, By Distribution Channel
- Chemotherapy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Global Chemotherapy Market, By Drugs, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Alkylating agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antimetabolites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anti-tumor antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Chemotherapy Market, By Cancer Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Chemotherapy Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Chemotherapy Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Chemotherapy Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
Amgen Inc.
Gilead Sciences, Inc.
Boehringer Ingelheim International GmbH.
AbbVie Inc.
Merck & Co., Inc.
Eureka Therapeutics, Inc.
Verismo Therapeutics, Inc.
Bayer AG
Autolus Therapeutics

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

化学療法市場：薬剤別、がんの種類別、投与経路別、流通チャネル別、地域別

Chemotherapy Market, By Drugs, By Cancer Type, By Route of Administration, By Distribution Channel, By Geography

市場力学：

当研究の主な特徴

目次

第1章分析目的と前提条件

第2章市場の展望

第3章市場力学・規制・動向の分析

第4章世界の化学療法市場：薬剤別、2019～2031年 (10億米ドル)

第5章世界の化学療法市場：がんの種類別、2019～2031年 (10億米ドル)

第6章世界の化学療法市場：投与経路別、2019～2031年 (10億米ドル)

第7章世界の化学療法市場：流通チャネル別、2019～2031年 (10億米ドル)

第8章世界の化学療法市場：地域別、2019～2031年 (10億米ドル)

第9章競合情勢

第10章アナリストの提言

第11章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Chemotherapy Market, By Drugs, 2019-2031, (USD Bn)

5. Global Chemotherapy Market, By Cancer Type, 2019-2031, (USD Bn)

6. Global Chemotherapy Market, By Route of Administration, 2019-2031, (USD Bn)

7. Global Chemotherapy Market, By Distribution Channel, 2019-2031, (USD Bn)

8. Global Chemotherapy Market, By Region, 2019 - 2031, Value (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

化学療法市場：薬剤別、がんの種類別、投与経路別、流通チャネル別、地域別

Chemotherapy Market, By Drugs, By Cancer Type, By Route of Administration, By Distribution Channel, By Geography

市場力学：

当研究の主な特徴

目次

第1章 分析目的と前提条件

第2章 市場の展望

第3章 市場力学・規制・動向の分析

第4章 世界の化学療法市場：薬剤別、2019～2031年 (10億米ドル)

第5章 世界の化学療法市場：がんの種類別、2019～2031年 (10億米ドル)

第6章 世界の化学療法市場：投与経路別、2019～2031年 (10億米ドル)

第7章 世界の化学療法市場：流通チャネル別、2019～2031年 (10億米ドル)

第8章 世界の化学療法市場：地域別、2019～2031年 (10億米ドル)

第9章 競合情勢

第10章 アナリストの提言

第11章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Chemotherapy Market, By Drugs, 2019-2031, (USD Bn)

5. Global Chemotherapy Market, By Cancer Type, 2019-2031, (USD Bn)

6. Global Chemotherapy Market, By Route of Administration, 2019-2031, (USD Bn)

7. Global Chemotherapy Market, By Distribution Channel, 2019-2031, (USD Bn)

8. Global Chemotherapy Market, By Region, 2019 - 2031, Value (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

第1章分析目的と前提条件

第2章市場の展望

第3章市場力学・規制・動向の分析

第4章世界の化学療法市場：薬剤別、2019～2031年 (10億米ドル)

第5章世界の化学療法市場：がんの種類別、2019～2031年 (10億米ドル)

第6章世界の化学療法市場：投与経路別、2019～2031年 (10億米ドル)

第7章世界の化学療法市場：流通チャネル別、2019～2031年 (10億米ドル)

第8章世界の化学療法市場：地域別、2019～2031年 (10億米ドル)

第9章競合情勢

第10章アナリストの提言

第11章参考文献と調査手法